Developer docs
API playgroundTry for free, no card

Search company profiles

Averix Bio

Full company profile

uuid002cwuk

Namestring
Averix Bio
Websiteurl
averixbio.com
Company typeenum
Private
Founded yearint
2018
Short descriptiontext

Averix Bio is a non-operating entity whose only public footprint is the parked domain averixbio.com listed on GoDaddy Auctions, with no verifiable products, team, funding, or customers in the source data.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
1–10
akta.pro rankint
HeadquartersWilson, United States
HQ citystring
Wilson
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Keyword5 values
biotechnology research, life sciences products, biological materials supply, bio laboratory services, biotech manufacturing
Product category
Biotechnology
Social media profiles3 records
Cost components1 value
Others
GTM typeB2B
B2B
Offering typeServices
Services
Core offering1 text field

No core offering could be identified. The averixbio.com domain is parked on GoDaddy Auctions and displays only a domain-for-sale landing page with no products, services, or company information.

Differentiator
Functional benefit
Problem solved
No data
Market position
Customer concentration

Classification, Details

Ideal customer profile1 record

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Core technology
Revenue estimate
Valuation estimate
Number of profiles
No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Averix Bio

Biotechnologyaverixbio.com

Averix Bio is a non-operating entity whose only public footprint is the parked domain averixbio.com listed on GoDaddy Auctions, with no verifiable products, team, funding, or customers in the source data.

Averix Bio firmographics

Firmographics
Name
Averix Bio
Website
https://averixbio.com
Company type
Private
Founded year
2018
Operating status
Operating
Headcount range
1–10 employees
Short description
Averix Bio is a non-operating entity whose only public footprint is the parked domain averixbio.com listed on GoDaddy Auctions, with no verifiable products, team, funding, or customers in the source data.
Ownership category
akta.pro rank

Where Averix Bio is headquartered

Location

Headquarters

HQ city
Wilson
HQ country
United States
HQ region
North America

Markets served

Averix Bio business model

Business model
GTM type
B2B
Offering type
Services
Cost components
Others

Averix Bio product offering

Product offering

Core offering

No core offering could be identified. The averixbio.com domain is parked on GoDaddy Auctions and displays only a domain-for-sale landing page with no products, services, or company information.

Differentiator

Problem solved

Functional benefit

Companies that use Averix Bio

Customer profile

Ideal customer profiles1 record

Averix Bio technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Averix Bio competitors and assessment

Company assessment

Market position

Customer concentration

Averix Bio social profiles

Digital presence

Averix Bio financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Averix Bio leadership team

Management profile

Number of profiles

Averix Bio funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Averix Bio M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Averix Bio

What does Averix Bio do?

No core offering could be identified. The averixbio.com domain is parked on GoDaddy Auctions and displays only a domain-for-sale landing page with no products, services, or company information.

When was Averix Bio founded?

Averix Bio was founded in 2018. It employs 1 to 10 people.

Where is Averix Bio based?

Averix Bio is headquartered in Wilson, United States, in the North America region.

Does Averix Bio have an API?

No public API is recorded for Averix Bio.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
PR NewswireCannabidiol (CBD) API Market to Record Rapid Growth with CAGR of 41.7% by 2030 - Exclusive Report by InsightAce AnalyticInsightAce Analytic Pvt. Ltd. published a market research report predicting the global Cannabidiol (CBD) API market will grow at a CAGR of 41.7% between 2022 and 2030, driven by increasing demand for health and wellness products, regulatory approvals, and expanding therapeutic applications. The report identifies key growth drivers including government funding for therapeutic research, partnerships between major market players, and rising patient adoption, while noting that FDA cautiousness on CBD approvals and high product prices remain significant challenges. Notable recent developments include 22nd Century Group's acquisition of GVB Biopharma in May 2022, Averix Bio's Drug Master File submission to the FDA, and DSM's exclusive global cooperation with Brains Bioceutical for cannabinoid-based pharmaceutical development.GlobeNewswireGeocann and Averix Bio form a strategic partnership to supply the global marketplace with pharmaceutical API phytocannabinoid ingredients formulated with a clinically proven drug delivery system technGeocann and Averix Bio announced a strategic partnership to supply U.S.-produced API phytocannabinoid ingredients with VESIsorb drug delivery technology to the global marketplace. The alliance focuses on South America, where Geocann has established sales and distribution infrastructure. The partnership aims to serve pharmaceutical, nutraceutical, cosmetic, and veterinary sectors.GlobeNewswireGeocann and Averix Bio form a strategic partnership to supply the global marketplace with pharmaceutical API phytocannabinoid ingredients formulated with a clinically proven drug delivery system technGeocann and Averix Bio announced a strategic partnership to supply U.S.-produced API phytocannabinoid ingredients and bioavailable formulations to the global marketplace, with Geocann focusing on South America. The partnership leverages Geocann's exclusive VESIsorb drug delivery system, which has shown improved cannabinoid bioavailability in peer-reviewed studies.Business Wire BlogAverix Bio Announces Submission of Drug Master File for its CBD Isolate in the U.S.Averix Bio submitted a Drug Master File (DMF 036798) to the FDA for its cannabidiol isolate, made from industrial hemp. The company's facility complies with cGMP and 21 CFR Parts 210/211, and it aims to supply pharmaceutical, cosmetics, nutraceutical, and veterinary markets.